British journal of Cancer |
Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer |
juil. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer |
juin. 16 |
|
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project |
juin. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations Open |
oct. 17 |
2 ♥ |
Cancers autres |
British journal of Cancer |
Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1 |
juil. 16 |
3 ♥ |
Cancers autres (hors CCR et CHC), Œsophage/Estomac |
British journal of Cancer |
Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with men |
aoû. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma |
Jan. 19 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach |
juin. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer |
nov. 17 |
3 ♥ |
Cancers autres |
British journal of Cancer |
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer |
sep. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
British journal of Cancer |
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy |
juil. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology). |
mar. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients |
aoû. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma |
Jan. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry |
sep. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2) |
sep. 15 |
2 ♥ |
Cancers autres (hors CCR et CHC), Œsophage/Estomac |
British journal of Cancer |
A phase 2 randomised study of veliparib plus FOLFIRI ± bevacizumab versus placebo plus FOLFIRI ± bevacizumab in metastatic colorectal cancer |
Jan. 19 |
1 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer |
aoû. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer |
mai. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Journal of the National Cancer Institute (JNCI) |
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands’ Susceptibility Gene Mutation Status |
mar. 19 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas |
Jan. 17 |
|
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Colorectal Cancer Incidence Patterns in the United States, 1974–2013 |
aoû. 17 |
3 ♥ |
Cancer colorectal (CCR) |